Cellular OS
00Cellular Performance OS · Personal Protocol v2.1

CELLULARPERFORMANCEOPERATINGSYSTEM

A research-led system for cognition, cellular energy, muscle, recovery, structural resilience and healthy aging.

The body is not a stack. It's an operating system.

Protocol
v2.1 · July 2026
Active components
21
Biological modules
6
Evidence types
6
Mission status · current recorded snapshotPersonal baseline · not medical advice
Protocol
vv2.1
July 2026
Active components
21
Validated by Jim
11
personal adoption
Current · to confirm
9
Working · to confirm
1
Systems tracked
6
biological modules
VO₂ max
45.3
mL/kg/min
Jim's current baseline
Resting HR
61
bpm
Jim's current baseline
HRV
36
ms
Jim's current baseline
01The problem

Conventional wellness sells capsules. The body runs on pathways.

Isolated ingredients and isolated promises collapse under measurement. The operating-system model treats inputs, pathways, interactions, outcomes and biomarkers as one connected loop.

Conventional model
  • Isolated ingredients
  • Isolated promises
  • Marketing benefits
  • No feedback loop
Operating-system model
  • Inputs mapped to pathways
  • Pathways mapped to outcomes
  • Outcomes mapped to biomarkers
  • Biomarkers close the loop
02The system map

Six systems, one loop.

Every ingredient is being mapped to a mechanism, an intended outcome and a relevant measurement. Some links are complete; others are still under review.

Brain & neural
Cellular energy
Muscle & protein
Structural tissue
Recovery & foundations
Biomarkers & feedback
03.5Pathway map

From component to intended outcome to measurement.

Six featured components. The measurement column stays honest — nothing is invented where scientific review is pending.

  • Creatine
    10 g
    Muscle, Protein & Physical Performance
    01
    System role · mechanism
    Phosphocreatine buffering for high-turnover ATP demand in muscle and brain.
    02
    Intended outcome
    Support strength, high-intensity capacity and possible cognitive resilience under load.
    03
    Module
    Muscle, Protein & Physical Performance · Module 03
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
  • Citicoline
    500 mg (baseline)
    Brain Performance
    01
    System role · mechanism
    Choline and cytidine donor for phospholipid synthesis and acetylcholine availability.
    02
    Intended outcome
    Support attention and cognitive performance during demanding cognitive work.
    03
    Module
    Brain Performance · Module 01
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
  • NMN
    800 mg
    Cellular Energy & Longevity
    01
    System role · mechanism
    Precursor investigated for NAD+ availability.
    02
    Intended outcome
    Investigated for effects related to NAD+ metabolism in adults.
    03
    Module
    Cellular Energy & Longevity · Module 02
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
  • Urolithin A
    700 mg
    Cellular Energy & Longevity
    01
    System role · mechanism
    Investigated for effects on mitophagy and mitochondrial function.
    02
    Intended outcome
    Investigated for muscle endurance and mitochondrial health in adults.
    03
    Module
    Cellular Energy & Longevity · Module 02
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
  • Omega-3
    Fish oil 4.8 g · EPA 1,728 mg + DHA 1,152 mg (2,880 mg EPA+DHA)
    Brain Performance
    01
    System role · mechanism
    Structural component of cell membranes; substrate for resolving mediators.
    02
    Intended outcome
    Support membrane composition and inflammation resolution.
    03
    Module
    Brain Performance · Module 01
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
  • Collagen
    10 g
    Structural Health
    01
    System role · mechanism
    Amino-acid substrate investigated for connective-tissue support when paired with vitamin C and loading.
    02
    Intended outcome
    Investigated for connective-tissue synthesis alongside training.
    03
    Module
    Structural Health · Module 04
    04
    Relevant measurement
    Relevant measurement mapping · research review pending
03Six biological modules · one protocol · one research library

Six biological modules. One protocol. One research library.

Modules 01–06 describe the six biological systems the protocol is organised around. Modules 07 and 08 are the protocol itself and the underlying research library.

04The reasoning chain

From intervention to measurable outcome.

Step 01
Intervention
Step 02
Biological mechanism
Step 03
System role
Step 04
Expected outcome
Step 05
Biomarker or metric
Step 06
Review · continue · modify · stop

Every intervention must be able to travel through this chain. Where a link is uncertain, that uncertainty is visible — not hidden behind a benefit claim.

05Current personal protocol

v2.1
July 2026

A personal record — not a prescription. Every dose is labelled and every change is versioned. Canonical record aligned July 2026.

Jim's personal protocol dose. Not a general
dosage recommendation.
Active components
21
Validated by Jim
11
Current · to confirm
9
Working · to confirm
1
06.5Benefits constellation

The architecture of outcomes.

Nodes are labelled only as intended outcome, established physiological role or research area. Never as "proven benefit".

Select a node

Hover or focus a node to see the exact ingredients connected to it, their evidence stage and personal status. Nodes are labelled only as intended outcome, established physiological role or research area — never as "proven benefit".

Text list · accessible fallback
  • Cognition
    Labelled as: intended outcome
    Creatine, Citicoline, Lion's Mane, L-Theanine
  • Focus
    Labelled as: intended outcome
    Citicoline, L-Theanine
  • Cellular energy
    Labelled as: established physiological role
    Creatine, NMN, Calcium alpha-ketoglutarate, Urolithin A, Taurine, Reduced glutathione
  • Muscle preservation
    Labelled as: established physiological role
    Creatine, Urolithin A, Whey isolate
  • Training capacity
    Labelled as: intended outcome
    Creatine, Urolithin A, Collagen
  • Recovery
    Labelled as: intended outcome
    L-Theanine, Glycine, L-Glutamine, Magnesium, Zinc gluconate
  • Connective tissue
    Labelled as: established physiological role
    Collagen, Glycine, L-Lysine, Vitamin C
  • Skin hydration
    Labelled as: research area
    Sodium hyaluronate
  • Joint support
    Labelled as: research area
    Sodium hyaluronate, Glucosamine sulfate
  • Antioxidant status
    Labelled as: established physiological role
    Reduced glutathione, Vitamin C
  • Healthy-aging research
    Labelled as: research area
    NMN, Calcium alpha-ketoglutarate
06.6Ingredient · system heatmap

Where each component sits in the system.

Ingredient × system relevance Primary Secondary None
Ingredient benefit heatmap. Intensity represents system relevance, not magnitude of benefit.
IngredientM01M02M03M04M05M06Personal protocolHuman evidenceReview pending
Creatine
Cellular energy substrate
Citicoline
Choline donor
Lion's Mane
Fungal extract
Omega-3 (fish oil)
Essential fatty acids
NMN
NAD+ precursor
Urolithin A
Mitophagy activator
Taurine
Conditionally essential amino acid
Reduced glutathione
Antioxidant tripeptide
Collagen peptides
Structural protein hydrolysate
L-Glutamine
Conditionally essential amino acid
Zinc gluconate
Essential mineral (as gluconate salt)
L-Theanine
Amino acid
Calcium alpha-ketoglutarate (Ca-AKG)
TCA intermediate
Glycine
Amino acid
L-Lysine
Essential amino acid
Vitamin C
Essential vitamin
Sodium hyaluronate
Glycosaminoglycan
Glucosamine sulfate
Aminosugar
Calcium
Essential mineral
Magnesium
Essential mineral
Whey isolate
Protein source

Intensity represents system relevance, not magnitude of benefit.

07Evidence framework

Evidence type is separate from confidence.

A human trial is not automatically strong evidence. A plausible mechanism is not proof of a meaningful outcome. No single ordering captures both dimensions — evidence type and confidence are recorded independently.

Evidence type
  • Human trialCategory
  • ObservationalCategory
  • PreclinicalCategory
  • MechanisticCategory
  • PersonalCategory
  • UnsupportedCategory

Where the evidence comes from — not how strong it is.

Confidence
  • HighLevel
  • ModerateLevel
  • LowLevel
  • Very lowLevel
  • Not assessedLevel

How much weight to place on the claim — assessed independently of type.

07.5Performance telemetry

Recorded values only.

Baseline signals
Recorded values only
Recovery status · insufficient longitudinal data
VO₂ max · trend
Resting HR · trend
HRV · trend
Personal context
Physiological context, not clinical assessment
Age
51years
Height
~185cm
Weight
~90kg
Bodyweight work
~200+ push-ups/day

Personal context — never medical advice. No optimal range is displayed unless a laboratory or reviewer explicitly supplies one.

08Biomarker preview

What isn't measured isn't managed.

Open dashboard
VO₂ max
Jim's current baseline
45.3mL/kg/min
Resting HR
Jim's current baseline
61bpm
HRV
Jim's current baseline
36ms

The dashboard distinguishes laboratory reference intervals, historical personal baselines, clinician targets and research-associated ranges. No invented "optimal" numbers.

Better performance does not come from continually adding more. It comes from understanding the system, measuring what changes and removing what does not earn its place.